Candidate driver genes in focal chromosomal aberrations of stage II colon cancer

Chromosomal instable colorectal cancer is marked by specific large chromosomal copy number aberrations. Recently, focal aberrations of 3 Mb or smaller have been identified as a common phenomenon in cancer. Inherent to their limited size, these aberrations harbour one or few genes. The aim of this study was to identify recurrent focal chromosomal aberrations and their candidate driver genes in a well‐defined series of stage II colon cancers and assess their potential clinical relevance. High‐resolution DNA copy number profiles were obtained from 38 formalin‐fixed, paraffin‐embedded colon cancer samples with matched normal mucosa as a reference using array comparative genomic hybridization. In total, 81 focal chromosomal aberrations were identified that harboured 177 genes. Statistical validation of focal aberrations and identification of candidate driver genes were performed by enrichment analysis and mapping copy number and mutation data of colorectal, breast, and pancreatic cancer and glioblastomas to loci of focal aberrations in stage II colon cancer. This analysis demonstrated a significant overlap with previously identified focal amplifications in colorectal cancer, but not with cancers from other sites. In contrast, focal deletions seemed less tumour type‐specific since they also showed significant overlap with focal deletions of other sites. Focal deletions detected were significantly enriched for cancer genes and genes frequently mutated in colorectal cancer. The mRNA expression of these genes was significantly correlated with DNA copy number status, supporting the relevance of focal aberrations. Loss of 5q34 and gain of 13q22.1 were identified as independent prognostic factors of survival in this series of patients. In conclusion, focal chromosomal copy number aberrations in stage II colon cancer are enriched in cancer genes that contribute to and drive the process of colorectal cancer development. DNA copy number status of these genes correlates with mRNA expression and some are associated with clinical outcome. Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  O. Beahrs.  The American Joint Committee on Cancer. , 1984, Bulletin of the American College of Surgeons.

[2]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[3]  L. Sobin,et al.  TNM classification of malignant tumors, fifth edition (1997) , 1997, Cancer.

[4]  M M Weiss,et al.  Comparative genomic hybridisation. , 1999, Molecular pathology : MP.

[5]  Christian A. Rees,et al.  Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[7]  Terry Speed,et al.  Normalization of cDNA microarray data. , 2003, Methods.

[8]  N. Carter,et al.  Array Comparative Genomic Hybridization Analysis of Colorectal Cancer Cell Lines and Primary Carcinomas , 2004, Cancer Research.

[9]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[10]  Terrence S. Furey,et al.  The UCSC Table Browser data retrieval tool , 2004, Nucleic Acids Res..

[11]  E. Birney,et al.  A survey of homozygous deletions in human cancer genomes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Pinkel,et al.  Array comparative genomic hybridization and its applications in cancer , 2005, Nature Genetics.

[13]  Terrence S. Furey,et al.  The UCSC Genome Browser Database: update 2006 , 2005, Nucleic Acids Res..

[14]  G. Thomas,et al.  Retention of chromosome arm 5q in stage II colon cancers identifies 83% of liver metastasis occurrences , 2006, Genes, chromosomes & cancer.

[15]  B. Ylstra,et al.  BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH) , 2006, Nucleic acids research.

[16]  R. Lothe,et al.  The order of genetic events associated with colorectal cancer progression inferred from meta‐analysis of copy number changes , 2006, Genes, chromosomes & cancer.

[17]  D. Albertson,et al.  Gene amplification in cancer. , 2006, Trends in genetics : TIG.

[18]  Wessel N. van Wieringen,et al.  CGHcall: Calling aberrations for array CGH tumor profiles. , 2008 .

[19]  Derek Y. Chiang,et al.  Characterizing the cancer genome in lung adenocarcinoma , 2007, Nature.

[20]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[21]  H. Grabsch,et al.  DNA Quality Assessment for Array CGH by Isothermal Whole Genome Amplification , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[22]  E. Kay,et al.  Formalin‐fixed paraffin‐embedded clinical tissues show spurious copy number changes in array‐CGH profiles , 2007, Clinical genetics.

[23]  David Haussler,et al.  The UCSC genome browser database: update 2007 , 2006, Nucleic Acids Res..

[24]  Gordon K. Smyth,et al.  A comparison of background correction methods for two-colour microarrays , 2007, Bioinform..

[25]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[26]  Sjoerd J. Vosse,et al.  Across array comparative genomic hybridization: A strategy to reduce reference channel hybridizations , 2008, Genes, chromosomes & cancer.

[27]  G. Parmigiani,et al.  Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers , 2008, Proceedings of the National Academy of Sciences.

[28]  E. Schröck,et al.  Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression , 2008, Gut.

[29]  C. Caldas,et al.  Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies. , 2008, Seminars in radiation oncology.

[30]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[31]  Toshihide Ueno,et al.  Chromosome copy number analysis in screening for prognosis‐related genomic regions in colorectal carcinoma , 2008, Cancer science.

[32]  B. Ylstra,et al.  DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[33]  Yong-shu He,et al.  [Structural variation in the human genome]. , 2009, Yi chuan = Hereditas.

[34]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[35]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[36]  Henry Z. Montes,et al.  TNM Classification of Malignant Tumors, 7th edition , 2010 .